Presentation TCT 2023 TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials Presenter: Rayyan Hemetsberger October 25, 2023
Presentation TCT 2023 TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials Presenter: Usman Naseer October 25, 2023
News Conference News TCT 2023 Comparing DCBs in De Novo CAD: Drugs, Design Matter Caitlin E. Cox October 25, 2023
Presentation TCT 2023 Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial Presenter: Giovanni De Maria October 25, 2023
Presentation TCT 2023 Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial Presenter: Myeong-Ki Hong October 25, 2023
Presentation TCT 2023 Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis Presenter: Robert Yeh October 25, 2023
Presentation TCT 2023 Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial Presenter: Ramon Varcoe October 25, 2023
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Conference News TCT 2023 More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact Yael L. Maxwell October 24, 2023
Presentation TCT 2023 TCT 641: Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention: a Meta-analysis of Randomized Trials Presenter: Jayakumar Sreenivasan October 24, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
Presentation TCT 2023 Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial Presenter: Martin Leon October 24, 2023
Presentation TCT 2023 TCT 191: Outcomes With Intravascular Imaging-guided, Functionally Guided, or Angiography-guided Percutaneous Coronary Intervention in Patients With or Without Acute Coronary Syndromes: A Network Meta-Analysis of Randomized Trials Presenter: Yuko Kiyohara October 24, 2023
Presentation TCT 2023 TCT 46: Intravascular Imaging for Complex PCI: A Meta-Analysis of Randomized Controlled Trials Presenter: Mohamed Hamed October 24, 2023
Presentation TCT 2023 TCT 31: Intravascular Imaging-Guided Versus Angiography-Guided PCI: Meta-analysis of 20 Randomized Controlled Trials Presenter: Doosup Shin October 24, 2023
News Daily News Sham Procedures in CV Research: What’s Sacrificed for Science? Caitlin E. Cox October 23, 2023
News Conference News TCT 2023 OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions Todd Neale October 23, 2023
Presentation TCT 2023 Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-analysis of the TWILIGHT and TICO Randomized Trials Presenter: Usman Baber October 23, 2023
News Daily News SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry Yael L. Maxwell October 20, 2023